May 2nd, 2025
Coronavirus Updates - Page 15
JNJ Stock Down 1% Now, Johnson & Johnson to Produce 900M COVID-19 Vaccine Doses by Q1 2021
By Tolu Ajiboye
April 15th, 2020
Johnson & Johnson is planning to produce close to 1 billion COVID-19 doses by March 2021 if its human trials go well. Meanwhile, despite a small fall now, JNJ is slowly climbing higher and higher.
Trump Temporarily Stops U.S. Payments to WHO, World’s COVID-19 Cases Close to 2M
By Andy Watson
April 15th, 2020
The U.S. is going to stop donations to the WHO amidst the outrageous coronavirus outbreak. The pandemic plunges the world into a global recession with a 3% global economy shrink.
Apple (AAPL) Stock Price Up 5% Yesterday, What Are the Reasons?
By Christopher Hamman
April 15th, 2020
Apple (AAPL) stock is doing quite well these days. This comes as good news after the iPhone maker was taking one beating after another at the stock market.
TSLA Stock Rises 5.16% in Pre-Market, Tesla’s China Car Registrations Surge in March
By Darya Rudz
April 15th, 2020
The number of Tesla car registrations in China rose 450% in March to reach 12,709 units. Some analysts believe backsliding is unlikely to take place in the upcoming days. Now TSLA stock is rising.
Trump Wants to Start Reopening U.S. Economy before May 1
By Teuta Franjkovic
April 15th, 2020
Trump wants to reopen the country already in the nearest future but all people in the U.S. still should exclusively follow strict social distancing guidelines at least through the end of April.
Pharma Giants Sanofi and GlaxoSmithKline Join Hands to Develop Coronavirus Vaccine
By Darya Rudz
April 15th, 2020
Within the partnership, Sanofi will contribute its S-protein COVID-19 antigen based on recombinant DNA technology, while GlaxoSmithKline will implement its proven pandemic adjuvant technology.
Inovio (INO) Stock Down 4% on Monday, 1% Today, Can It Be Multimillionaire-maker Stock?
By Andy Watson
April 14th, 2020
Inovio Pharmaceuticals alongside Moderna are edging close to providing a vaccine for the novel coronavirus. However, Inovio (INO) stock is down these days.
Trump’s Desire to Reopen U.S. Faces Criticism as Testing Rate Remains Low
By Steve Muchoki
April 14th, 2020
On Monday, President Donald Trump said that he wants to reopen the country before the schedule. However, he got a lot of criticism as the country faces challenges in mass coronavirus testing.
First U.S. Coronavirus Stimulus Checks Deposited, Here Is When You Can Get Yours
By Christopher Hamman
April 14th, 2020
If you have filed your returns between 2018 and 2019 and have direct deposit enabled, then your coronavirus stimulus check should arrive soon.
PayPal, Intuit and Square Offer Loans to Small Businesses as Part of Coronavirus Relief Program
By Darya Rudz
April 14th, 2020
PayPal, Intuit and Square got approved to take part in the coronavirus relief program and offer loans to small businesses. Meanwhile, PayPal, and Square stocks closed in the green on April 13, 0.13% and 0.35% up correspondingly. Intuit shares slightly tanked.
WHO: 70 COVID-19 Vaccines in Progress, U.S. Moderna and Inovio Are Among Leaders
By Darya Rudz
April 13th, 2020
Three of the COVID-19 vaccine developers have already entered the stage of human trials. These are CanSino, Inovio Pharmaceuticals, and Moderna. Other 67 potential COVID-19 vaccines are still in preclinical evaluation.
How Coronavirus Pandemic Is Affecting Fintech Companies
By Tolu Ajiboye
April 13th, 2020
Fintech companies, among others, have seen some effect of the current coronavirus pandemic. Let’s take a look at the ongoing changes.
How to Save Money During Coronavirus Pandemic: 5 Really Working Ways
By Christopher Hamman
April 13th, 2020
Saving money amid the coronavirus outbreak may become a problem for many people. Here are a few tips that can help you.
DIS Stock Up 3.39%, Disney to Furlough 43K Workers, Cover Health Insurance for 12 Months
By Darya Rudz
April 13th, 2020
Starting on April 19, Disney will furlough 43,000 Disney World workers. They will still be eligible for their medical, dental, vision, and life insurance benefits. DIS stock is in the green.
Gilead Sciences (GILD) Stock Fell 2%, Remdesivir Shows Potential for Coronavirus Treatment
By Teuta Franjkovic
April 12th, 2020
Remdesivir, Gilead Sciences’ experimental drug for patients with severe COVID-19 infection, showed promise in an early analysis, raising tentative hope that the first treatment for the novel virus may be on the horizon.